Denis Guilloteau

Affiliations: 
Universite de Tours 
Google:
"Denis Guilloteau"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vala C, Mothes C, Chicheri G, et al. (2020) Fully automated radiosynthesis of [F]LBT999 on TRACERlab FX and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain. Ejnmmi Radiopharmacy and Chemistry. 5: 26
Ribeiro MJ, Vercouillie J, Arlicot N, et al. (2020) Usefulness of PET With [F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment. Frontiers in Neurology. 11: 754
Ribeiro M, Vercouillie J, Arlicot N, et al. (2020) Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment Frontiers in Neurology. 11
Arlicot N, Vercouillie J, Malherbe C, et al. (2019) PET imaging of Dopamine Transporter with [18F]LBT-999: initial evaluation in healthy volunteers. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of...
Chalon S, Vercouillie J, Payoux P, et al. (2019) The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use. Frontiers in Medicine. 6: 90
Elie J, Vercouillie J, Arlicot N, et al. (2019) Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [F] PET tracer. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1-7
Malherbe C, Bidault R, Netter C, et al. (2019) Development of a Fast and Facile Analytical Approach to Quantify Radiometabolites in Human Plasma Samples Using Ultra High Performance Liquid Chromatography American Journal of Analytical Chemistry. 10: 185-201
Dupont AC, Largeau B, Guilloteau D, et al. (2018) The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases. Contrast Media & Molecular Imaging. 2018: 7043578
Beaufils E, Vercouillie J, Vierron E, et al. (2018) Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes. Clinical Nuclear Medicine. 43: e103-e108
Ribeiro MS, Vercouillie J, Gissot V, et al. (2018) Le 18F-LBT-999, le nouveau traceur TEP du DAT ? MéDecine NucléAire. 42: 137-138
See more...